Use of anti-FAM19A5 antibodies for treating atherosclerosis
US12247070B2 · kind B2 · utility
0Cited by
42References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 26, 2019 |
| Grant date | Mar 11, 2025 |
| Priority date | — |
| Expiry date | Apr 30, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat an atherosclerosis in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.